Eosinophilic Fasciitis: A Rare Immune-Related Adverse Effect of Immune Checkpoint Inhibitor Therapy
Diagnosis and management of EF in the setting of cancer immunotherapy requires close collaboration between patient’s oncologist, dermatologist, and rheumatologist.